Upstream Processing

Oct 21, 2016
By BioPharm International Editors
Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.
Oct 15, 2016
BioPharm International
Experts discuss recent advances in cell viability testing methods in bioreactors.
Oct 15, 2016
BioPharm International
BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Oct 07, 2016
By BioPharm International Editors
WuXi AppTec’s new biomanufacturing facility is its third facility in the Philadelphia, PA Navy Yard.
Oct 04, 2016
By BioPharm International Editors
Xellia added laboratory space and personnel in Zagreb, Croatia to work on anti-infective products that combat the antimicrobial resistance problem.
Oct 03, 2016
By BioPharm International Editors
ViraTherapeutics will develop its VSV-GP therapy alone and in combination with other therapies.
Oct 01, 2016
BioPharm International
A new virus-retentive membrane may be used to filter chemical-defined cell culture media for risk mitigation.
Sep 19, 2016
By BioPharm International Editors
GE Healthcare’s GE BioPark Cork will hold four KUBio manufacturing facilities; GE will also collaborate with NIBRT for biopharmaceutical training.
Sep 01, 2016
By BioPharm International Editors
The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.
Sep 01, 2016
BioPharm International
Model effectiveness is determined by the quality and composition of the data inputs.
native1_300x100
lorem ipsum